key: cord-0713084-vq1d9iu8
authors: Arora, Pooja; Sardana, Kabir; Mathachan, Sinu Rose; Malhotra, Purnima
title: Herpes zoster after inactivated COVID‐19 vaccine: A cutaneous adverse effect of the vaccine
date: 2021-06-15
journal: J Cosmet Dermatol
DOI: 10.1111/jocd.14268
sha: 8abbed69a511e4970fd469067569100a77bfdb9e
doc_id: 713084
cord_uid: vq1d9iu8

While the emergent focus worldwide has shifted to vaccines for achieving herd immunity to COVID-19, the adverse effects of these vaccines are important to recognise as it impacts their widespread acceptance. In January 2021, the Central Drugs Standard Control Organization (CDSCO) in India granted emergency use authorization to two vaccines Covishield® (AstraZeneca's vaccine manufactured by Serum Institute of India) and Covaxin® (manufactured by Bharat Biotech Limited).

To the Editor, While the emergent focus worldwide has shifted to vaccines for achieving herd immunity to COVID-19, the adverse effects of these vaccines are important to recognize as it impacts their widespread acceptance.

In January 2021, the Central Drugs Standard Control Organization 

COVID-19 Vaccine FAQs

COVID-19:Common side effects

Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies

Herpes zoster following inactivated COVID-19 vaccine: A coexistence or coincidence?

Reactivation of herp herpesvirus infections after vaccinations?

Varicella-zoster virusspecific immune responses in elderly recipients of a herpes zoster vaccine